UnitedHealth (UNH) Stock Analysis
Financial ServicesHospital & Medical Service Plans
Q2 2026 · +0.4% revenue · +0.3% revenue
Beat the trendvs trailing 3-quarter avg
Revenue▼−8.5 ppvs trend
Net income▲+114.8 ppvs trend
Diluted EPS▲+114.4 ppvs trend
Free cash flow▲+38.7 ppvs trend
Outperformed in 3 of 4 metrics
How the cash was deployedQ2 2026
Operating cash flow$19.96B
$1.56B (7.8 %)
Share buybacks$1.65B (8.2 %)
Dividends paid$4.09B (20.5 %)
Debt repayment$2.50B (12.5 %)
Returned to shareholders this quarter$5.74B▼ −39.3%
Last 8 quarters of revenueLatest quarter highlighted. Q4 reconstructed from the annual filing.
+0.4% +0.3%
100.82BQ3 24
100.81BQ4 24*
109.58BQ1 25
111.62BQ2 25
113.16BQ3 25
113.22BQ4 25*
111.72BQ1 26
112.03BQ2 26
* Q4 is reconstructed from the annual filing (FY − Q1 − Q2 − Q3), since the SEC does not require a Q4 10-Q.
RevenueReversal
$112.03B▲+0.4% ▲+0.3%
99.80B
98.86B
100.82B
100.81B
109.58B
111.62B
113.16B
113.22B
111.72B
112.03B
Net incomeReversal
$5.48B▲+61.0% ▼−12.7%
−1.41B
4.22B
6.05B
5.54B
6.29B
3.41B
2.35B
10.00M
6.28B
5.48B
Free cash flowSlowing
$18.40B▲+69.4% ▲+126%
401.00M
6.29B
19.25B
−8.09B
4.56B
10.86B
15.91B
−18.73B
8.15B
18.40B
Diluted Reversal
$6.04▲+61.5% ▼−12.5%
-1.53
4.54
6.51
5.99
6.85
3.74
2.59
0.05
6.90
6.04
Margins
Gross marginAccelerating
88.1 %▼−0.3 pp ▼−0.5 pp
88.92
88.53
88.26
87.64
88.69
88.34
88.90
88.80
88.52
88.06
Operating marginReversal
7.1 %▲+2.5 pp ▼−0.9 pp
7.95
7.97
8.64
7.71
8.32
4.61
3.81
0.34
8.05
7.13
Net marginReversal
4.9 %▲+1.8 pp ▼−0.7 pp
-1.41
4.26
6.01
5.50
5.74
3.05
2.07
0.01
5.62
4.90
| Metric | Q2 2025Same quarter, prior year | Q1 2026Previous quarter | Q2 2026Latest quarter | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue | $111.62B | $111.72B | $112.03B | +0.4% | +0.3% |
| Cost of revenue | $13.02B | $12.82B | $13.38B | +2.7% | +4.3% |
| Gross profit | $98.60B | $98.90B | $98.66B | +0.1% | −0.2% |
| Operating expenses | $106.47B | $102.73B | $104.04B | −2.3% | +1.3% |
| Operating income | $5.15B | $8.99B | $7.99B | +55.2% | −11.1% |
| Net income | $3.41B | $6.28B | $5.48B | +61.0% | −12.7% |
| Diluted | $3.74 | $6.90 | $6.04 | +61.5% | −12.5% |
| Operating cash flow | $12.64B | $8.91B | $19.96B | +57.9% | +124% |
| $1.78B | $763.00M | $1.56B | −12.4% | +105% | |
| Free cash flow | $10.86B | $8.15B | $18.40B | +69.4% | +126% |
| Gross margin | 88.3 % | 88.5 % | 88.1 % | −0.3 pp | −0.5 pp |
| Operating margin | 4.6 % | 8.0 % | 7.1 % | +2.5 pp | −0.9 pp |
| Net margin | 3.1 % | 5.6 % | 4.9 % | +1.8 pp | −0.7 pp |